Sorrento Therapeutics (SRNE) Competitors $0.0024 +0.00 (+84.62%) As of 07/11/2025 03:46 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRNE vs. SPRB, ENVB, GLMD, ELAB, AFMD, PRFX, ADTX, PBM, OGEN, and GRIShould you be buying Sorrento Therapeutics stock or one of its competitors? The main competitors of Sorrento Therapeutics include Spruce Biosciences (SPRB), Enveric Biosciences (ENVB), Galmed Pharmaceuticals (GLMD), PMGC (ELAB), Affimed (AFMD), PainReform (PRFX), Aditxt (ADTX), Psyence Biomedical (PBM), Oragenics (OGEN), and GRI Bio (GRI). These companies are all part of the "pharmaceutical products" industry. Sorrento Therapeutics vs. Its Competitors Spruce Biosciences Enveric Biosciences Galmed Pharmaceuticals PMGC Affimed PainReform Aditxt Psyence Biomedical Oragenics GRI Bio Sorrento Therapeutics (NASDAQ:SRNE) and Spruce Biosciences (NASDAQ:SPRB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability. Which has more risk and volatility, SRNE or SPRB? Sorrento Therapeutics has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Spruce Biosciences has a beta of 2.4, suggesting that its stock price is 140% more volatile than the S&P 500. Is SRNE or SPRB more profitable? Sorrento Therapeutics has a net margin of 0.00% compared to Spruce Biosciences' net margin of -555.23%. Sorrento Therapeutics' return on equity of 0.00% beat Spruce Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Sorrento TherapeuticsN/A N/A N/A Spruce Biosciences -555.23%-62.10%-47.49% Which has better valuation & earnings, SRNE or SPRB? Spruce Biosciences has lower revenue, but higher earnings than Sorrento Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSorrento Therapeutics$60.32M0.02-$572.84MN/AN/ASpruce Biosciences$4.91M0.77-$47.92M-$1.32-0.07 Do analysts prefer SRNE or SPRB? Spruce Biosciences has a consensus target price of $1.75, suggesting a potential upside of 1,857.49%. Given Spruce Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Spruce Biosciences is more favorable than Sorrento Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sorrento Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Spruce Biosciences 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals have more ownership in SRNE or SPRB? 0.0% of Sorrento Therapeutics shares are owned by institutional investors. Comparatively, 91.7% of Spruce Biosciences shares are owned by institutional investors. 2.6% of Sorrento Therapeutics shares are owned by company insiders. Comparatively, 6.9% of Spruce Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor SRNE or SPRB? In the previous week, Sorrento Therapeutics' average media sentiment score of 0.00 equaled Spruce Biosciences'average media sentiment score. Company Overall Sentiment Sorrento Therapeutics Neutral Spruce Biosciences Neutral SummarySpruce Biosciences beats Sorrento Therapeutics on 7 of the 11 factors compared between the two stocks. Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRNE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNE vs. The Competition Export to ExcelMetricSorrento TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.32M$211.03M$5.62B$9.10BDividend YieldN/AN/A5.24%4.00%P/E RatioN/AN/A28.1020.27Price / Sales0.02253.11429.7099.23Price / CashN/A22.4437.4658.16Price / BookN/A6.158.045.49Net Income-$572.84M-$96.61M$3.18B$250.45M7 Day PerformanceN/A12.09%3.61%4.77%1 Month PerformanceN/A10.43%4.04%7.67%1 Year PerformanceN/A6.57%29.99%16.38% Sorrento Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNESorrento Therapeutics0.3766 of 5 stars$0.00+84.6%N/A-78.2%$1.32M$60.32M0.00800SPRBSpruce Biosciences2.0663 of 5 stars$0.07+0.7%$1.75+2,313.8%-84.2%$3.06M$4.91M-0.0820Gap DownENVBEnveric Biosciences2.6961 of 5 stars$1.21-2.4%$10.00+726.4%-82.8%$3.06MN/A-0.0320GLMDGalmed Pharmaceuticals1.4295 of 5 stars$1.84+1.7%N/A-46.4%$2.99MN/A-0.1120Positive NewsGap DownELABPMGC0.6161 of 5 stars$2.16+0.9%N/A-99.7%$2.94M$1.71M0.0018News CoverageAFMDAffimed2.862 of 5 stars$0.18-34.9%$3.62+1,895.9%-96.5%$2.92M$877K0.00200Gap DownHigh Trading VolumePRFXPainReform0.6638 of 5 stars$1.44+2.1%N/A-30.5%$2.84MN/A-0.014Trending NewsADTXAditxtN/A$1.28-3.8%N/A-100.0%$2.82M$130K0.0060PBMPsyence Biomedical0.9987 of 5 stars$5.33+8.6%N/A-97.4%$2.80MN/A0.00N/AGap UpOGENOragenics0.0704 of 5 stars$3.82-5.7%N/A-95.8%$2.73M$40K-0.545GRIGRI Bio3.1437 of 5 stars$1.29+1.6%$22.00+1,605.4%-94.1%$2.72MN/A-0.111Positive News Related Companies and Tools Related Companies Spruce Biosciences Competitors Enveric Biosciences Competitors Galmed Pharmaceuticals Competitors PMGC Competitors Affimed Competitors PainReform Competitors Aditxt Competitors Psyence Biomedical Competitors Oragenics Competitors GRI Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRNE Stock Alerts